Members share their approaches to China's traceability regulations, the extent of which can depend on business processes or the nature of the pharmacuetical product itself. Healthcare institutions, pharmacies and medical insurance are now required to scan drug traceability codes to manage reimbursement. The recently-amended Drug Administration Law (DAL) puts further compliance pressure on foreign MAHs.
Who Can Join?
TraceLink Customers
Meeting Schedule
Time: 9am EDT, 3pm CET, 9pm SGT
Cadence: First Tuesday of the month
Duration: 1 hour
Upcoming Meetings (2026)
7 Jul / 4 Aug / 1 Sep / 6 Oct
Topics from Recent Meetings
- 2026 Drug Administration Law Revisions
- Accessible Product Information: Pilot
- NHSA Medical Insurance Oversight Plan 2026-2030
- Traceability for Traditional Chinese Medicine (TCM)
- NMPA Opinions: Pharmaceutical Distribution and Contract Manufacturing
Join the China Special Interest Group
The 2019 China Drug Administration Law completely revamped the previous regulations, yet some are remaining "stuck" in the old way of doing things. Join fellow members to discuss how to comply with the current regulations, how to connect to the new NMPA system, the pathway to move to GS1 coding, manage the expanded set of reports and data, and provide data to downstream partners. If you're new to China traceability, drop us a note and we can send you an introductory recorded presentation.